Verified Clinical Trials Selected To Present Data at the Annual 2014 ASCP (NCDEU) Meeting Highlighting the Mounting Issue of Dual Enrollment in Clinical Trials
Verified Clinical Trials, the research subject clinical trials database registry and a recognized expert in the field of dual enrollment in clinical trials, will present at the 2014 ASCP (NCDEU) meeting. Verified Clinical Trials (VCT) is the largest research subject clinical trial database registry in North America and offers a remedy to a growing problem that plagues the research industry.
Garden City, New York (PRWEB) May 12, 2014
Verified Clinical Trials (VCT), the leading North American research subject clinical trials database registry to prevent dual enrollment in clinical research trials, announced that Kerri Weingard (COO) will present a poster at the annual ASCP (NCDEU) meeting June 16-19th 2014 in Hollywood, Florida. Ms. Weingard will present the Verified Clinical Trials data regarding dual enrollment in CNS trials. She will discuss the professional research subject's impact on clinical research data, research subject safety, clinical trial research subject databases, and VCT’s web-based system.
The annual conference, has become the key meeting in this domain, bringing together academic investigators, industry scientists, U.S. and international regulators from FDA and EMA, National Institutes of Health components including NIMH, NIDA, NIAAA and many other professionals working in drug development and clinical trials.
The poster session to be presented by Ms. Weingard is entitled, “The Impact of Implementing a National Research Subject Database to Prevent Dual Enrollment in Early and Late Phase Central Nervous System Trials."
“ASCP is a gathering of the largest and most significant companies and attracts many of the most talented minds serving the industry” remarked Kerri Weingard, COO of Verified Clinical Trials stated, "We are so enthused that the committee elected to recognize the issue within our industry and has chosen Verified Clinical Trials to further explore these concerns and solutions."
Ms. Weingard, who served as the representative from Verified Clinical Trials (VCT), was delighted to be a presenter at this year’s conference. “To have the ability to bring the issue of attempted dual enrollment to light is well overdue. There is real compelling data regarding the issue in the industry, especially in CNS trials.” said Ms. Weingard. “It has been an honor to have our poster selected and to focus on the growing problem of dual enrollment in CNS trials and the clinical trial industry as a whole."
About Verified Clinical Trials:
Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value added services to the clinical research site, CRO, and Pharmaceutical Sponsor, that prove invaluable with regards to financial and legal issues and liabilities. For more information, RSVP to or visit http://www.verifiedclinicaltrials.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/vctNCDEUcnstrials/researchSubjectRegistry/prweb11822624.htm